These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-006482-16 COMPARISON BETWEEN EPOYETIN ALONE ET EPOYETIN ASSOCIATED TO DIFFERENTIATING TERAPY WITH ACID 13-CIS-RETINOICO AND VITAMIN D3 DIIDROXILATED IN MYELODISPLASTIC SYNDROMES WITHOUT BLASTS EXCESS. CONF... not-yet-due
Listed as ongoing, but also has a completion date 2014-000200-10 A Randomized Phase III study of Decitabine (DAC) with or without Hydroxyurea (HY) versus HY in patients with advanced proliferative Chronic Myelomonocytic Leukemia (CMML) 2021-08-16 bad-data
Completed, but no date Terminated 2018-003542-17 Early and low dose Deferasirox (3.5 mg/kg FCT) to suppress NTBI and LPI as early intervention to prevent tissue iron overload in lower risk MDS Dose bassa e precoce di Deferasirox ( 3.5 mg/kg FCT) ... bad-data